Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of LNG-IUS, Copper IUD, and Oral Contraceptives on Quality of Life
NCT01805817Phase 4Withdrawn
- Sponsor
- Istanbul Education Research Hospital
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of avatrombopag, drospirenone, ethinyl estradiol in contraception, sponsored by Istanbul Education Research Hospital. Planned start Dec 2012; status: withdrawn.
02
Drugs
avatrombopagdrospirenoneethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01805817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805817.